INTERNATIONAL PATENT: FUNDACIO INSTITUT D'INVESTIGACIO BIOMÈDICA DE BELLVITGE (IDIBELL), INSTITUT CATALA D'ONCOLOGIA (ICO) FILES APPLICATION FOR "ONCOLYTIC ADENOVIRUS WITH CONTROLLED REPLICATION"

GENEVA, Oct. 4 -- FUNDACIO INSTITUT D'INVESTIGACIO BIOMÈDICA DE BELLVITGE (IDIBELL) (Avinguda Gran via de l'Hospitalet 199E-08908 Hospitalet de Llobregat, Barcelona), INSTITUT CATALA D'ONCOLOGIA (ICO) (Gran Via de L'Hospitalet, 199-203E-08908 L'Hospitalet de Llobregat, Barcelona) filed a patent application (PCT/EP2025/058307) for "ONCOLYTIC ADENOVIRUS WITH CONTROLLED REPLICATION" on Mar 26, 2025. With publication no. WO/2025/202311, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MORENO OLIE, Rafael (Lluis Jover, 47,...